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Introduction
Both selenomethionine (SeMet) based multiwavelength
anomalous diffraction (MAD) phasing and protein produc-
tion in baculovirus expression vector systems have greatly
enhanced the scope and speed of macromolecular crystal-
lography, but the apparent incompatibility of these two
powerful techniques presents an obstacle to many struc-
ture determinations. The use of either technique alone is
essentially routine, and although their individual use is
growing dramatically (Figure 1), their combined use is vir-
tually unknown. As of 14th July 1999, the Protein Data
Bank contained no deposited coordinates for structures
solved using MAD phasing on baculovirus produced
SeMet-labeled proteins.
SeMet-based MAD phasing
The MAD approach to obtaining phase information has
proved to be one of the most powerful in protein crystal-
lography, and its use for a variety of problems has been
expanding [1,2]. The increasing availability of synchrotron
sources [3], improved algorithms for extracting phase
information from MAD data [2,4,5], the development of
cryocrystallography [6], and advances in area detector
technology [7,8] have all contributed to the rapid and
widespread popularity of MAD techniques. While MAD
can be employed with various elements, selenium has
become the atom of choice. Selenium has an experimen-
tally convenient X-ray absorption edge (0.98 Å) and can be
introduced into proteins biosynthetically through the sub-
stitution of selenomethionine for methionine. SeMet-
labeled proteins usually differ only slightly, or not at all,
from their native counterparts [9]. 
Baculovirus expression
The overexpression of SeMet-labeled proteins in
Escherichia coli has become routine [10,11]. However,
many interesting proteins cannot be satisfactorily pro-
duced in bacterial expression systems. These proteins typ-
ically require the post-translational processing machinery
of eukaryotic cells, and their expression in bacterial
systems leads to proteins that are insoluble, improperly
folded and/or degraded. The baculovirus expression
vector system has emerged as a powerful method for
protein production in eukaryotic cells [12]. In this system,
insect cells are infected with a baculovirus containing the
DNA encoding the protein of interest. Expression of the
desired gene product is often controlled by the viral poly-
hedrin promoter, which leads to very high protein expres-
sion (up to 50% of total cellular protein late in the
infectious cycle).
Baculovirus overexpression has been a successful means
to produce proteins that require post-translational modifi-
cations, such as glycosylation, or that are too large to
express in bacteria. This system has not proved generally
useful for producing SeMet-labeled proteins. One obsta-
cle to the production of SeMet-labeled proteins using the
baculovirus system is the greater fragility of insect cells
compared to bacteria. The insect cells often die or
produce only small amounts of protein in response to
mechanical stress. A second problem associated with the
insect cell expression system is that the successful label-
ing of the protein requires the absence of the unlabeled
form of the molecule. It is difficult, or impossible, to
Figure 1
The annual number of structures solved using proteins expressed
from baculovirus and the annual number of structures solved by
SeMet-based MAD phasing. Data were obtained from
http://www.biomednet.com/db/msd/ (Macromolecular
Structures Database).
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purify SeMet-labeled protein from a mixture of labeled
and unlabeled protein, and methionine will be preferen-
tially used in protein biosynthesis over SeMet. As a conse-
quence, SeMet-labeled protein must be expressed in a
system without methionine. This is easily achieved with
bacteria, which have the ability to grow in minimal media,
but insect cells require a complex mixture of amino acids,
peptides and lipids to support growth. It has proven diffi-
cult to devise a medium that will allow the cells to prolif-
erate at a rate that supports viral infection and protein
expression, while simultaneously maintaining a depleted
level of an essential amino acid.
Although there have been at least two reports of SeMet-
labeled proteins produced in insect cells [13,14], the
ability to produce MAD-quality protein crystals of these
proteins has not been reported, as the structures of both
were solved without using MAD techniques on the insect
cell expressed protein [14,15]. We report here a protocol
for the overexpression of SeMet-labeled proteins in the
baculovirus/insect cell system; the labeled protein was
used to solve the structure of palmitoyl protein
thioesterase 1 (PPT1) using MAD phasing. A systematic
study of conditions for cell growth was necessary to deter-
mine a procedure that produced protein in sufficient
quantities with a high level of SeMet incorporation. We
believe that this is the first such systematic analysis, and
we expect that the protocol should be generally applicable
to a variety of proteins.
Case study — PPT1
Project background
PPT1 is a 279-residue glycosylated lysosomal hydrolase
that can be overexpressed in soluble form in high yield in
insect cells, but not in E. coli [16,17]. Crystals of native
PPT1 were obtained that diffracted to 2.25 Å resolution,
but phase determination proved to be difficult. Severe
nonisomorphism between native crystals manifested itself
in significant variations of the unit-cell dimensions and
unacceptably high merging R factors (greater than 25%)
between datasets from different crystals. This nonisomor-
phism and the lack of any known structure with significant
homology precluded the use of both multiple isomor-
phous replacement and molecular replacement tech-
niques. Variations in the post-translational processing of
glycoproteins often leads to an ensemble of molecules
with different sugar chains that cannot easily be purified
from one another. Although N-linked glycosylation in
insect cells is primarily made up of high-mannose sugar
chains, heterogeneity is still a problem due to variation in
the number of sugar residues on different molecules. Such
heterogeneous glycosylation can prevent crystallization in
severe cases, and may lead to nonisomorphism if the vari-
able sugar regions are involved in crystal packing. We
suspect that the nonisomorphism of PPT1 crystals was
due at least in part to the three N-linked glycosylation
sites on PPT1. Upon completion of the structure determi-
nation, it became apparent that one intermolecular contact
involves the glycosylated regions of two adjacent symme-
try-related molecules.
MAD phasing seemed to be the most practical approach to
structure determination, and attempts were made to
obtain heavy-atom derivatives for data collection at the
gold and mercury LIII absorption edges without success.
The sequence of PPT1 suggested that it would be a good
candidate for SeMet MAD phasing, having eight methion-
ines among its 279 residues.
SeMet-labeling protocol
PPT1 with a high level of SeMet can be produced using a
five-step protocol developed for insect cells in bioreactor
culture: cell growth, infection, methionine depletion,
SeMet labeling and harvest (Figure 2). With the excep-
tion of the depletion and labeling steps, this is a standard
baculovirus expression protocol. A stirred tank bioreactor
with a 10 L working volume was used for the large-scale
production of labeled PPT1 (Bellco Glass Inc., Vineland
NJ). The bioreactor consists of a glass vessel fitted with
probes and hardware used to control the dissolved oxygen
level and temperature of the culture. The strict control of
these environmental conditions along with the use of
gentle agitation greatly reduces cellular stress in bioreac-
tor experiments as compared to shaker flasks. Sf21 cells
were inoculated into the bioreactor at an initial cell
density of 1 × 105 cells ml–1 in 10 L of serum-free medium
(Cyto-SF9, Kemp Biotechnologies Inc., Frederick MD).
The temperature of the culture was maintained at 27°C
and the dissolved oxygen level at 60% air saturation. The
cells were expanded to a density of 1 × 106 cells ml–1 and
infected with the recombinant PPT1 baculovirus using a
multiplicity of infection of five (five virus particles per
cell). Thirty-six hours after infection the cells were asepti-
cally removed from the bioreactor and dispensed into
sterile 1 L centrifuge bottles. The cells were sedimented
at 300 × g and 20°C using a swinging-bucket rotor. The
cell pellets were resuspended in 2 L of Grace’s Medium
without methionine (LTI, Gaithersburg MD) supple-
mented with 10% v/v dialyzed fetal bovine serum (Kemp
Biotechnologies, Inc.) and returned to the bioreactor. The
volume in the vessel was adjusted to 10 L using the
methionine-deficient medium with dialyzed serum, and
the culture was maintained for 4 h to allow the cells to
deplete intracellular pools of methionine. Following the
incubation period, the cells were aseptically removed
from the bioreactor and sedimented at 300 × g and 20°C
as described above. The cell pellets were resuspended in
2 L of Grace’s Medium without methionine, supple-
mented with 10% v/v dialyzed fetal bovine serum and
50 mg l–1 SeMet (Calbiochem, San Diego CA). The cell
suspension was returned to the bioreactor and the
volume in the vessel was adjusted to 10 L using the
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methionine-deficient medium with dialyzed serum and
SeMet. The culture was maintained for an additional 36 h
and the cells were sedimented at 800 × g for 10 min at
4°C. PPT1 is secreted into the culture media, so the
pellets were discarded and the supernatant pooled and
held at 4°C prior to purification.
Results of SeMet-labeled PPT1 production
The purification protocol for SeMet-labeled PPT1 was
identical to that for native PPT1 (data not shown).
Because we had already expressed the protein in an oxida-
tive environment, we did not take any special precautions
to prevent oxidation of SeMet in PPT1 during purification
and crystallization.
Levels of SeMet incorporation in bacterial expression
systems are usually measured by mass spectrometry (MS)
techniques, but MS is not useful with variably glycosy-
lated proteins like PPT1. The mass differences resulting
from the different numbers of sugars on individual protein
molecules can exceed the mass differences due to substi-
tution of SeMet for methionine. Amino acid analysis can
also be used to establish the incorporation of SeMet.
Methionine and SeMet are sensitive to the conditions of
the analysis, however, and can be lost due to oxidation and
hydrolysis. To partially account for this sensitivity, we
estimated the degree of substitution by comparing the
methionine recovered from analysis of SeMet-labeled
PPT1 to the methionine recovered from analysis of native
PPT1, which gave an incorporation ratio of ~76%. The
two prior reports of SeMet-labeled protein expression in
insect cells reported substitution levels of ~84% for
human choriogonadotropin [13], which was estimated
using the same method as for PPT1, and ~95% for the
peptide exchange factor H2-M from mouse [14], which
was estimated by loss of methionine. These estimates are
subject to considerable error, as loss of methionine due to
hydrolysis and oxidation can lead to underestimates of the
methionine content by as much as 30% [18,19].
We crystallized SeMet-labeled PPT1 under conditions
nearly identical to those of native PPT1 (data not shown).
X-ray fluorescence measurements on SeMet PPT1 crystals
at the Cornell High Energy Synchrotron Source (CHESS)
F2 beamline indicated a strong absorption edge at
12.666 KeV, confirming the successful incorporation of
selenium into the crystal. The absorption peak was shifted
~5 eV higher in energy than the peak of the reference sele-
nium foil. We collected diffraction data on a crystal of
~0.2 mm × 0.2 mm × 0.2 mm using an area detector
systems corporation quantum-4 CCD detector [8] at
CHESS F2 using three wavelengths (λ1 = 0.9791 Å, edge;
λ2 = 0.9788 Å, peak; λ3 = 0.9633 Å, remote) and the inverse
beam method. The data were reduced using MOSFLM
[20] and the CCP4 software package [21]. The Rsym for
data to 3.0 Å was 7.2% for λ1 and 7.8% for λ2 and λ3. Com-
pleteness was greater than 99% at all three wavelengths. 
The difference Patterson methods implemented in
SOLVE [22] (http://www.solve.lanl.gov) were used to
locate the selenium atom positions. The program located
eight peaks with an overall figure of merit of 0.65. Phasing
with SHARP [4] followed by density modification with
SOLOMON [23] improved the figure of merit to 0.91.
The resulting solvent-flattened electron-density map was
readily interpretable, and the initial model was built using
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Figure 2
Protocol for the expression of SeMet-labeled
PPT1 in baculovirus. See text for details. The
media used in the different stages are color
coded: yellow, Cyto-SF9 serum-free medium;
red, Grace’s medium without methionine plus
10% (v/v) dialyzed fetal bovine serum; blue,
Grace’s medium without methionine plus 10%
(v/v) dialyzed fetal bovine serum and
50 mg l–1 SeMet.
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the program O [24]. Full details on the structure determi-
nation of PPT1 will be published elsewhere.
Discussion 
The production strategy presented above was developed
over time. We originally attempted to adapt the Sf21 cell
line to grow in a medium containing dialyzed serum and
SeMet. The cells exhibited a decreased growth rate in this
medium, which caused a decrease in product expression.
We abandoned this protocol in favor of one where we
replaced the normal growth medium with the labeling
medium immediately prior to the addition of the virus.
This protocol also resulted in a low level of product
expression that may have been due to stresses placed on
the cell population by the medium exchange.
We reasoned that the yield might be improved by waiting
to introduce the stress of a medium exchange until after
the infection cycle was initiated. We allowed the infection
of the cells and the initial 36 h of the infection cycle to
proceed in the growth medium, and then changed the
medium to the methionine-deficient Grace’s medium.
This ‘starvation’ medium, introduced in an attempt to
lower the intracellular pool of methionine, was not a true
minimal medium, as supplementation with 10% dialyzed
fetal bovine serum was essential for cell viability. We
tested starvation times of 4, 8 and 16 h and found that cell
viability decreased in the samples incubated for 8 or 16 h.
The 4 h incubation was selected on the basis of this obser-
vation. Omission of the starvation step led to a low level of
SeMet incorporation. After the 4 h incubation, the
medium was exchanged for the labeling medium and the
expression was allowed to proceed to the post-infection
time that was determined to be optimal for this protein
(72 h post-infection).
The general success of this protocol depends on defining
conditions that maintain the viability of the culture under
the stressful conditions imposed by the labeling medium.
We would suggest that investigators applying this protocol
to other proteins maintain 24 h as the maximum initial
post-infection incubation phase and 4 h as the starvation
period. The 24 h time period is of sufficient length to
allow the infection to initialize and protein expression to
begin. Waiting longer may dilute the labeled protein pop-
ulation with unlabeled material. On the basis of the PPT1
results, a 4 h starvation period is able to deplete methion-
ine reserves enough to produce product that is sufficiently
enriched in SeMet for MAD phasing. The optimal length
of the incubation in the labeling medium should be deter-
mined for each protein of interest, and will depend on the
dynamics of expression of that particular protein.
The mechanical and nutritional sensitivity of the insect
cells must not be overlooked. In addition to the require-
ment for fetal bovine serum in the starvation and labeling
media, we found that higher concentrations of SeMet
(100 mg l–1) led to premature cell death, but the cells
could grow in 50 mg l–1 SeMet. Extreme care has to be
taken when handling the cells during media exchange,
because in their stressed state they are extremely suscepti-
ble to mechanical rupture. We found that the controlled
environmental conditions and gentle agitation rates
achievable using a bioreactor were ideal for this application
and that our best results were obtained using this instru-
ment. Trials using static culture, roller bottles, shaker
flasks and spinner flasks produced unsatisfactory results.
Baculovirus expression and MAD phasing are both critical
techniques in this era of high-throughput structural
biology, expanding the variety of proteins that can be
overexpressed and streamlining the structure determina-
tion process. The marriage of these two techniques,
SeMet labeling in insect cells and MAD phasing, is likely
to be widely adopted.
Note added in proof
After submission of this article, the production of a SeMet-
labeled fragment of the human tumor necrosis factor
TRAF2 in baculovirus with ~40% incorporation, as mea-
sured by mass spectrometry, was reported (McWhirter,
S.M., Pullen, S.S., Holton, J.M., Crute, J.J., Kehry, M.R. &
Alber, T. (1999). Crystallographic analysis of CD40 recog-
nition and signaling by human TRAF2. Proc. Natl Acad. Sci.
96, 8408-8413). The authors used a strategy for SeMet
labeling similar to the one described in this article, except
that their methionine depletion time was only 1 h com-
pared to the 4 h in our protocol, and they used a concentra-
tion of 100 mg l–1 SeMet rather than the 50 mg l–1 SeMet
used in our protocol. They determined the structure of
TRAF2 complexed with a CD40 peptide using MAD
phasing on both an Hg derivative and a SeMet derivative.
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